Cargando…
Therapeutic use of Aldara™ in chronic myeloid leukemia
The potent clinical responses seen in patients with chronic myeloid leukemia (CML) after administration of donor-specific lymphocytes, as well as the correlation between the presence of antigen specific T cells and prolonged remission in these patients, suggests a role for the immunological control...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790884/ https://www.ncbi.nlm.nih.gov/pubmed/17254347 http://dx.doi.org/10.1186/1479-5876-5-4 |